2020
Pharmacology
Amin H, Schindler J. Pharmacology. 2020, 235-241. DOI: 10.1007/978-3-030-52552-1_19.ChaptersConcomitant medical comorbiditiesManagement of patientsStroke therapeuticsMedical comorbiditiesAcute strokeSecondary preventionCerebrovascular diseaseVascular neurologistsClinical indicationsPharmacological basisNeurologistsTherapeuticsHypertensionComorbiditiesHyperlipidemiaThrombosisOutpatientsPatientsInternistsCardiologistsStrokeDiseaseSeverityPreventionPharmacology
2016
Pharmacology
Amin H, Schindler J. Pharmacology. 2016, 177-183. DOI: 10.1007/978-3-319-39605-7_19.ChaptersConcomitant medical comorbiditiesManagement of patientsStroke therapeuticsMedical comorbiditiesAcute strokeSecondary preventionCerebrovascular diseaseVascular neurologistsClinical indicationsPharmacological basisNeurologistsTherapeuticsHypertensionComorbiditiesHyperlipidemiaThrombosisOutpatientsPatientsInternistsCardiologistsStrokeDiseaseSeverityPreventionPharmacology
2014
Cardioembolic Stroke: Practical Considerations for Patient Risk Management and Secondary Prevention
Amin H, Nowak RJ, Schindler JL. Cardioembolic Stroke: Practical Considerations for Patient Risk Management and Secondary Prevention. Postgraduate Medicine 2014, 126: 55-65. PMID: 24393752, DOI: 10.3810/pgm.2014.01.2725.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsManagement of patientsCE strokeCardioembolic strokeAtrial fibrillationNew anticoagulation therapiesMonitoring of patientsPatient risk managementAnticoagulation therapyVentricular dysfunctionIschemic strokeSecondary preventionEjection fractionPatent foramenStroke eventsValvular diseaseEarly recurrenceHigh morbidityCardiac mechanismPatient's mechanismPatientsStrokeFibrillationPreventionSecondary risk managementMorbidity